Teleflex (TFX) Competitors

In the previous week, Zimmer Biomet had 7 more articles in the media than Teleflex. MarketBeat recorded 10 mentions for Zimmer Biomet and 3 mentions for Teleflex. Zimmer Biomet's average media sentiment score of 0.24 beat Teleflex's score of 0.00 indicating that Zimmer Biomet is being referred to more favorably in the media.

Zimmer Biomet presently has a consensus price target of $103.33, suggesting a potential upside of 16.04%. Teleflex has a consensus price target of $155.20, suggesting a potential upside of 24.15%. Given Teleflex's stronger consensus rating and higher probable upside, analysts clearly believe Teleflex is more favorable than Zimmer Biomet.

88.9% of Zimmer Biomet shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Comparatively, 0.7% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.1%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Zimmer Biomet pays out 23.4% of its earnings in the form of a dividend. Teleflex pays out -5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Zimmer Biomet has a beta of 0.49, meaning that its stock price is 51% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Zimmer Biomet has a net margin of 9.48% compared to Teleflex's net margin of -39.67%. Zimmer Biomet's return on equity of 13.12% beat Teleflex's return on equity.

Zimmer Biomet has higher revenue and earnings than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

In the previous week, Penumbra had 4 more articles in the media than Teleflex. MarketBeat recorded 7 mentions for Penumbra and 3 mentions for Teleflex. Penumbra's average media sentiment score of 0.39 beat Teleflex's score of 0.00 indicating that Penumbra is being referred to more favorably in the media.

Penumbra has higher earnings, but lower revenue than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Penumbra has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

88.9% of Penumbra shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Penumbra has a net margin of 10.67% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Penumbra's return on equity.

Penumbra currently has a consensus target price of $367.07, suggesting a potential upside of 14.97%. Teleflex has a consensus target price of $155.20, suggesting a potential upside of 24.15%. Given Teleflex's stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than Penumbra.

Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Baxter International pays out -1.9% of its earnings in the form of a dividend. Teleflex pays out -5.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teleflex is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Baxter International had 9 more articles in the media than Teleflex. MarketBeat recorded 12 mentions for Baxter International and 3 mentions for Teleflex. Baxter International's average media sentiment score of 0.10 beat Teleflex's score of 0.00 indicating that Baxter International is being referred to more favorably in the media.

Baxter International has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

Baxter International presently has a consensus target price of $21.73, suggesting a potential downside of 10.70%. Teleflex has a consensus target price of $155.20, suggesting a potential upside of 24.15%. Given Teleflex's stronger consensus rating and higher possible upside, analysts clearly believe Teleflex is more favorable than Baxter International.

Baxter International has a net margin of -9.27% compared to Teleflex's net margin of -39.67%. Baxter International's return on equity of 16.57% beat Teleflex's return on equity.

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 0.7% of Teleflex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Teleflex has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Teleflex pays an annual dividend of $1.36 per share and has a dividend yield of 1.1%. Smith & Nephew SNATS pays an annual dividend of $0.59 per share and has a dividend yield of 2.2%. Teleflex pays out -5.8% of its earnings in the form of a dividend.

Teleflex has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.53, suggesting that its stock price is 47% less volatile than the broader market.

Smith & Nephew SNATS has a net margin of 0.00% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Smith & Nephew SNATS's return on equity.

In the previous week, Teleflex and Teleflex both had 3 articles in the media. Smith & Nephew SNATS's average media sentiment score of 0.25 beat Teleflex's score of 0.00 indicating that Smith & Nephew SNATS is being referred to more favorably in the news media.

Teleflex presently has a consensus price target of $155.20, suggesting a potential upside of 24.15%. Smith & Nephew SNATS has a consensus price target of $31.91, suggesting a potential upside of 17.25%. Given Teleflex's stronger consensus rating and higher probable upside, research analysts plainly believe Teleflex is more favorable than Smith & Nephew SNATS.

Smith & Nephew SNATS has higher revenue and earnings than Teleflex.